BMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/25 17. Bleeker WA, Hayes VM, Karrenbeld A, Hofstra RM, Hermans J, Buys CC, Plukk JT: Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer. Am J Gastroenterol 2000, 95:2953-7 18. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RAEM, Moriya Y, van de Velde CJH, van Krieken JHJM: Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001, 195:171-178 19. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, et al: A national cancer institute workshop on microsatellite in- stability for cancer detection and familial predisposition: de- velopment of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58:5248-5257 20. Marcus VA, Madlensky L, Gryfe R, Kim H, Millar A, Temple LKF, Hsieh E, Hiruki T, Narod S, Bapat BV, et al: Immunohistochemis- try for hMLH1 and hMSH2: a practical test for DNA mis- match repair-deficient tumors. Am J Surg Pathol 1999, 23:1248- 55 21. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, et al: Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002, 20:1043-1048 22. Mutter GL, Wada H, Faquin WC, Enomoto T: K-ras mutations ap- pear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis. Mol Pathol 1999, 52:257-62 23. Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, et al: Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 2001, 158:1517-21 24. Andreyev HJN, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N, et al: Kirsten ras mutations in patients with colorectal cancer: the "RAS- CAL II" study. Br J Cancer 2001, 85:692-96 25. Hugh TJ, Dillon SA, O'Dowd G, Getty B, Pignatelli M, Poston GJ, Kin- sella AR: B-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 1999, 82:504-511 26. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW: Mutational analysis of the APC/B-catenin/Tcf pathway in colorectal cancer. Can- cer Res 1998, 58:1130-34 27. Miyaki M, Iijma T, Kimura J, Yasuno M, Mori T, Hayasi Y, Koike M, Shi- tara N, Iwama T, Kuroki T: Frequent mutation of B-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 1999, 59:4506-9 Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/2/25/prepub Publish with BioMed Central and every scientist can read your work free of charge "BioMedcentral will be the most significant development for disseminating the results of biomedical research in our lifetime." Paul Nurse, Director-General, Imperial Cancer Research Fund Publish with BMC and your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours - you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/manuscript/ BioMedcentral.com editorial@biomedcentral.com Page 8 of 8 (page number not for citation purposes)